Advanced therapies deserve special treatment

Patients are waiting for novel therapies like ATMPs, bacteriophages, and mRNA-based options. To deliver these life-changing treatments, you need the agility to switch between different batches and therapies quickly. Automating the aseptic filling process in gloveless isolators shortens these changeover times.

Close up of SA25 Aseptic Filling Workcell with operator

Resources

Customer story: WuXi Biologics

This CDMO reached its first GMP batch release 15 months after purchasing a workcell from Cytiva.

Closed robotic workcells

Learn how they differ from conventional systems and how your drug product operations can benefit.

Standardization and flexibility

You don’t have to choose between the two – and they actually complement each other.

Vial, syringes and cartridge filling on the SA25 Aseptic Filling Workcell.

Gain speed to GMP filling

Learn how aseptic filling technology can give you speed advantage to GMP filling

Reduce risk for personalized medicines

With precious therapies like personalized medicines, reducing contamination risk is essential. Gloveless, robotic aseptic filling workcells from Cytiva remove the human operator from the process, therefore eliminating one of the greatest sources of contamination and maintaining drug product quality.

Gloveless operation of the Microcell Vial Filler

Build your filling facility

Some companies believe outsourcing the filling step to a contract development and manufacturing organization (CDMO) is the only viable option. You might be surprised at how quickly you can build your own capabilities, so you can maintain control of your whole advanced therapy manufacturing process.

Learn more